Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-09-26
2006-09-26
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100
Reexamination Certificate
active
07112405
ABSTRACT:
Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration in vivo, ex vivo and in vitro are presented. These methods and compositions involve cells and cell-free extracts with altered levels or activities of a protein from the RAD52 epistasis group, the mismatch repair group and/or the excision repair group.
REFERENCES:
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5565350 (1996-10-01), Kmiec
patent: 5700470 (1997-12-01), Saito et al.
patent: 5731181 (1998-03-01), Kmiec
patent: 5795972 (1998-08-01), Kmiec
patent: 5801154 (1998-09-01), Baracchini
patent: 5871984 (1999-02-01), Kmiec
patent: 5912340 (1999-06-01), Kutyavin
patent: 5928638 (1999-07-01), Uchida et al.
patent: 5945339 (1999-08-01), Holloman
patent: 5955363 (1999-09-01), Lewis
patent: 6004804 (1999-12-01), Kumar
patent: 6136601 (2000-10-01), Meyer
patent: 6261841 (2001-07-01), Cohen et al.
patent: 6271360 (2001-08-01), Metz
patent: 6391564 (2002-05-01), Haaf et al.
patent: 2002/0119570 (2002-08-01), Yoon
patent: 2003/0051270 (2003-03-01), Kmiec et al.
patent: 2003/0217377 (2003-11-01), Kmiec et al.
patent: WO 90/12084 (1990-10-01), None
patent: WO 99/14226 (1999-03-01), None
patent: WO 99/32619 (1999-07-01), None
patent: WO 99/58702 (1999-11-01), None
patent: WO 00/56748 (2000-09-01), None
patent: WO 00/63397 (2000-10-01), None
patent: WO 00/66604 (2000-11-01), None
patent: WO 01/15740 (2001-03-01), None
patent: WO 01/24615 (2001-04-01), None
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/73002 (2001-10-01), None
patent: WO 01/92512 (2001-12-01), None
patent: WO 02/10364 (2002-02-01), None
patent: WO 02/26967 (2002-04-01), None
Baumann et al. Role of the Human RAD51 Protein in Homologous Recombination and Double Strande-Break Repair, TIBS, 1998, vol. 23, p. 247-251.
Alber et al., “Nucleotide Sequence of the Triose Phosphate Isomerase Gene ofSaccharomyces cerevisiae”, J. Mol. Appl. Genet1:419-34 (1982).
Alexeev et al., “Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide,”Nature Biotech. 16:1343-1346 (1998).
Blau, “Current Status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis”,Baillieres Clin. Haematol11:257-275 (1998).
Blouin et al., “Altered Hematopoiesis in Murine Sickle Cell Disease”,Blood94:1451-1459 (1999).
Campbell et al., “Homologous recombination involving small single-stranded oligonucleotides in human cells,”New Biologist1:223-227 (1989).
Chan et al., “Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide,”J. Biol. Chem. 274:11541-11548 (1999).
Chan et al., “Triplex DNA: fundamentals, advances, and potential applications for gene therapy,”J. Mol. Med. 75:267-282 (1997).
Cole-Strauss et al., “Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide,”Science273:1386-1389 (1996).
Crystal, Ronald G., “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,”Science270: 404-410 (1995).
Culver et al., “Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides,”Nat. Biotechnol. 17:989-993 (1999).
Fabry et al., “Second generation knockout sickle mice: the effect of HbF”,Blood97:410-418 (2001).
Gamper et al., “A plausible mechanism for gene correction by chimeric oligonucleotides,”Biochemistry39(19): 5808-16 (2000).
Gamper et al., “The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts,”Nucleic Acids Res. 28:4332-4339 (2000).
Helene, et al., “The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides”Anticancer Drug Des. 6(6):569-84 (1991).
Helene et al., “Control of Gene Expression by Triple Helix-Forming Oligonucleotides”,Ann. N. Y. Acad. Sci. 660:27-36 (1992).
Heyer, “The search for the right partner: Homologous pairing and DNA strand exchange proteins in eukaryotes”,Experientia50(3):223-233 (1994).
Igoucheva et al., “Targeted gene correction by small single-stranded oligonucleotides in mammalian cells, ”Gene Therapy8:391-399 (2001).
Kaji et al., “Gene and Stem Cell Therapies,”JAMA285(5): 545-550 (2001).
Kmiec et al., “Targeted gene repair in mammalian cells using chimeric RNA/DNA oligonucleotides,”Cold Spring Harbor Monograph Series36: 643-670 (1999).
Kren et al., “Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide,”Proc. Natl. Acad. Sci. USA96:10349-10354 (1999).
Kunzelmann et al., “Gene targeting of CFTR DNA in CF epithelial cells,”Gene Ther. 3:859-867 (1996).
Liu et al., “In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides,”Nucl. Acids Res. 29(20): 4238-50 (2001).
Maher, “DNA Triple-Helix Formation: An Approach to Artificial Gene Repressors”,Bioessays14(12):807-15 (1992).
Moerschell et al., “Transformation of yeast with synthetic oligonucleotides,”Proc. Natl. Acad. Sci. USA85:524-528 (1988).
Ørum et al., “Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids,”Clinical Chemistry45(11): 1898-1905 (1999).
Paques et al., “Multiple Pathways of Recombination Induced by Double-Strand Breaks inSaccharomyces cerevisiae”, Microbiol. and Molec. Biol. Rev. 63(2):349-404 (1999).
Rando et al., “Rescue of dystrophin expression inmdxmouse muscle by RNA/DNA oligonucleotides,”Proc. Natl. Acad. Sci. USA97:5363-5368 (2000).
Rice et al., “The potential of nucleic acid repair in functional genomics,”Nature Biotech. 19(4): 321-26 (2001).
Santisteban et al., “Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: Implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA,”Human Molec. Genetics4(11): 2081-87 (1995).
Sayers et al., “5′-3′ Exonucleases in Phosphorothioate-based Oligonucleotide-directed Mutagenesis,”Nucleic Acids Research16(3): 791-801 (1988).
Spangrude et al., “Purification and Characterization of Mouse Hematopoietic Stem Cells”,Science214:58-62 (1988).
Thacker et al., “A surfeit of RAD51-like genes?”Trends Genet. 15: 166-68 (1999).
Thompson et al., “Homologous recombinatorial repair of DNA ensures mammalian chromosome stability”,Mutations Res. 477:131-153 (2001).
Vasquez et al., “Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells,”Nucl. Acids Res. 27:1176-1181 (1999).
Vasquez et al., “Specific mutations induced by triplex-forming oligonucleotides in mice,”Science290:530-532 (2000).
Verma et al., “Gene Therapy- Promises, Problems, and Prospects,”Nature389: 239-242 (1997).
Weiss et al., “Molecular cloning and characterization of the yeast RAD10 gene and expression of RAD10 protein inE. coli,” The EMBO Journal4(6): 1575-1582 (1985).
Woolf et al., “Toward the therapeutic editing of mutated RNA sequences,”Proc. Natl. Acad. Sci. USA92: 8298-8302 (1995).
Xu et al., “Activation of human γ-globin gene expression via triplex-forming oligonucleotide (TFO)-directed mutations in the γ-globin gene 5′ flanking region,”Gene242:219-228 (2000).
Yamamoto et al., “Strand-specificity in the transformation of yeast with synthetic oligonucleotides,”Genetics131:811-819 (1992).
Yanez et al., “Therapeutic gene targeting,”Gene Therapy5:149-15
Kmiec Eric B.
Liu Li
Rice Michael C.
Horlick Kenneth R.
McCarter & English LLP
Tung Joyce
University of Delaware
LandOfFree
Compositions and methods for enhancing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhancing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhancing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3572779